Literature DB >> 8610337

Can graft endothelial cells initiate a host anti-graft immune response?

J S Pober1, C G Orosz, M L Rose, C O Savage.   

Abstract

Mesh：

Substances：

Year:  1996        PMID： 8610337     DOI： 10.1097/00007890-199602150-00001

Source DB:  PubMed          Journal:  Transplantation        ISSN： 0041-1337            Impact factor:   4.939


× No keyword cloud information.
  24 in total

Review 1.  Antiphospholipid antibodies and the endothelium.

Authors:  B J Hunt; M A Khamashta
Journal:  Curr Rheumatol Rep       Date:  2000-06       Impact factor: 4.592

2.  Bladder cancer immunogenicity: expression of CD80 and CD86 is insufficient to allow primary CD4+ T cell activation in vitro.

Authors:  S J Pettit; S Ali; E O'Flaherty; T R Griffiths; D E Neal; J A Kirby
Journal:  Clin Exp Immunol       Date:  1999-04       Impact factor: 4.330

3.  Intravital microscopy identifies selectins that regulate T cell traffic into allografts.

Authors:  Thomas R Jones; Nozomu Shirasugi; Andrew B Adams; Thomas C Pearson; Christian P Larsen
Journal:  J Clin Invest       Date:  2003-12       Impact factor: 14.808

Review 4.  The endothelium: physiological functions and role in microcirculatory failure during severe sepsis.

Authors:  H Ait-Oufella; E Maury; S Lehoux; B Guidet; G Offenstadt
Journal:  Intensive Care Med       Date:  2010-05-05       Impact factor: 17.440

5.  Hyperbaric oxygen therapy and liver transplantation.

Authors:  Vijayaragavan Muralidharan; Chris Christophi
Journal:  HPB (Oxford)       Date:  2007       Impact factor: 3.647

6.  Endothelial cell activation. A central pathophysiological process.

Authors:  B J Hunt; K M Jurd
Journal:  BMJ       Date:  1998-05-02

7.  A comparison of the antigen-presenting capabilities of class II MHC-expressing human lung epithelial and endothelial cells.

Authors:  A C Cunningham; J G Zhang; J V Moy; S Ali; J A Kirby
Journal:  Immunology       Date:  1997-07       Impact factor: 7.397

8.  Factors affecting human T cell engraftment, trafficking, and associated xenogeneic graft-vs-host disease in NOD/SCID beta2mnull mice.

Authors:  Bruno Nervi; Michael P Rettig; Julie K Ritchey; Hanlin L Wang; Gerhard Bauer; Jon Walker; Mark L Bonyhadi; Ronald J Berenson; Julie L Prior; David Piwnica-Worms; Jan A Nolta; John F DiPersio
Journal:  Exp Hematol       Date:  2007-08-30       Impact factor: 3.084

9.  Dermal microvascular injury in the human peripheral blood lymphocyte reconstituted-severe combined immunodeficient (HuPBL-SCID) mouse/skin allograft model is T cell mediated and inhibited by a combination of cyclosporine and rapamycin.

Authors:  A G Murray; J S Schechner; D E Epperson; P Sultan; J M McNiff; C C Hughes; M I Lorber; P W Askenase; J S Pober
Journal:  Am J Pathol       Date:  1998-08       Impact factor: 4.307

10.  Cross-reactivity of herpesvirus-specific CD8 T cell lines toward allogeneic class I MHC molecules.

Authors:  Alexis Morice; Béatrice Charreau; Bérangère Neveu; Sophie Brouard; Jean-Paul Soulillou; Marc Bonneville; Elisabeth Houssaint; Nicolas Degauque
Journal:  PLoS One       Date:  2010-08-12       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.